カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のクリスビタ注射市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Crysvita Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19251）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19251
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：70
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のクリスビタ注射市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

クリスビタ注射市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のクリスビタ注射の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

クリスビタ注射市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・10mg/mL、20mg/mL、30mg/mL

用途別セグメントは次のように区分されます。
・こども、大人

世界のクリスビタ注射市場の主要な市場プレーヤーは以下のとおりです。
・Kyowa Kirin、Ultragenyx Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、クリスビタ注射製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なクリスビタ注射メーカーの企業概要、2019年～2022年までのクリスビタ注射の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なクリスビタ注射メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別クリスビタ注射の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのクリスビタ注射の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのクリスビタ注射市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびクリスビタ注射の産業チェーンを掲載しています。
・第13、14、15章では、クリスビタ注射の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- クリスビタ注射の概要
- 種類別分析（2017年vs2021年vs2028年）：10mg/mL、20mg/mL、30mg/mL
- 用途別分析（2017年vs2021年vs2028年）：こども、大人
- 世界のクリスビタ注射市場規模・予測
- 世界のクリスビタ注射生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Kyowa Kirin、Ultragenyx Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：10mg/mL、20mg/mL、30mg/mL
・用途別分析2017年-2028年：こども、大人
・クリスビタ注射の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・クリスビタ注射のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・クリスビタ注射のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・クリスビタ注射の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・クリスビタ注射の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Crysvita Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Crysvita Injection market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Children accounting for % of the Crysvita Injection global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 10 mg/mL segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Crysvita Injection include Kyowa Kirin, Ultragenyx Pharmaceutical, , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Crysvita Injection market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
10 mg/mL
20 mg/mL
30 mg/mL
Market segment by Application can be divided into
Children
Adults
The key market players for global Crysvita Injection market are listed below:
Kyowa Kirin
Ultragenyx Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Crysvita Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Crysvita Injection, with price, sales, revenue and global market share of Crysvita Injection from 2019 to 2022.
Chapter 3, the Crysvita Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Crysvita Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Crysvita Injection market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Crysvita Injection.
Chapter 13, 14, and 15, to describe Crysvita Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Crysvita Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Crysvita Injection Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 10 mg/mL
1.2.3 20 mg/mL
1.2.4 30 mg/mL
1.3 Market Analysis by Application
1.3.1 Overview: Global Crysvita Injection Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Children
1.3.3 Adults
1.4 Global Crysvita Injection Market Size & Forecast
1.4.1 Global Crysvita Injection Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Crysvita Injection Sales in Volume (2017-2028)
1.4.3 Global Crysvita Injection Price (2017-2028)
1.5 Global Crysvita Injection Production Capacity Analysis
1.5.1 Global Crysvita Injection Total Production Capacity (2017-2028)
1.5.2 Global Crysvita Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Crysvita Injection Market Drivers
1.6.2 Crysvita Injection Market Restraints
1.6.3 Crysvita Injection Trends Analysis
2 Manufacturers Profiles
2.1 Kyowa Kirin
2.1.1 Kyowa Kirin Details
2.1.2 Kyowa Kirin Major Business
2.1.3 Kyowa Kirin Crysvita Injection Product and Services
2.1.4 Kyowa Kirin Crysvita Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Ultragenyx Pharmaceutical
2.2.1 Ultragenyx Pharmaceutical Details
2.2.2 Ultragenyx Pharmaceutical Major Business
2.2.3 Ultragenyx Pharmaceutical Crysvita Injection Product and Services
2.2.4 Ultragenyx Pharmaceutical Crysvita Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Crysvita Injection Breakdown Data by Manufacturer
3.1 Global Crysvita Injection Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Crysvita Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Crysvita Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Crysvita Injection Manufacturer Market Share in 2021
3.4.2 Top 6 Crysvita Injection Manufacturer Market Share in 2021
3.5 Global Crysvita Injection Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Crysvita Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Crysvita Injection Market Size by Region
4.1.1 Global Crysvita Injection Sales in Volume by Region (2017-2028)
4.1.2 Global Crysvita Injection Revenue by Region (2017-2028)
4.2 North America Crysvita Injection Revenue (2017-2028)
4.3 Europe Crysvita Injection Revenue (2017-2028)
4.4 Asia-Pacific Crysvita Injection Revenue (2017-2028)
4.5 South America Crysvita Injection Revenue (2017-2028)
4.6 Middle East and Africa Crysvita Injection Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Crysvita Injection Sales in Volume by Type (2017-2028)
5.2 Global Crysvita Injection Revenue by Type (2017-2028)
5.3 Global Crysvita Injection Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Crysvita Injection Sales in Volume by Application (2017-2028)
6.2 Global Crysvita Injection Revenue by Application (2017-2028)
6.3 Global Crysvita Injection Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Crysvita Injection Sales by Type (2017-2028)
7.2 North America Crysvita Injection Sales by Application (2017-2028)
7.3 North America Crysvita Injection Market Size by Country
7.3.1 North America Crysvita Injection Sales in Volume by Country (2017-2028)
7.3.2 North America Crysvita Injection Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Crysvita Injection Sales by Type (2017-2028)
8.2 Europe Crysvita Injection Sales by Application (2017-2028)
8.3 Europe Crysvita Injection Market Size by Country
8.3.1 Europe Crysvita Injection Sales in Volume by Country (2017-2028)
8.3.2 Europe Crysvita Injection Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Crysvita Injection Sales by Type (2017-2028)
9.2 Asia-Pacific Crysvita Injection Sales by Application (2017-2028)
9.3 Asia-Pacific Crysvita Injection Market Size by Region
9.3.1 Asia-Pacific Crysvita Injection Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Crysvita Injection Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Crysvita Injection Sales by Type (2017-2028)
10.2 South America Crysvita Injection Sales by Application (2017-2028)
10.3 South America Crysvita Injection Market Size by Country
10.3.1 South America Crysvita Injection Sales in Volume by Country (2017-2028)
10.3.2 South America Crysvita Injection Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Crysvita Injection Sales by Type (2017-2028)
11.2 Middle East & Africa Crysvita Injection Sales by Application (2017-2028)
11.3 Middle East & Africa Crysvita Injection Market Size by Country
11.3.1 Middle East & Africa Crysvita Injection Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Crysvita Injection Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Crysvita Injection and Key Manufacturers
12.2 Manufacturing Costs Percentage of Crysvita Injection
12.3 Crysvita Injection Production Process
12.4 Crysvita Injection Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Crysvita Injection Typical Distributors
13.3 Crysvita Injection Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Crysvita Injection Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Crysvita Injection Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Kyowa Kirin Basic Information, Manufacturing Base and Competitors
Table 4. Kyowa Kirin Major Business
Table 5. Kyowa Kirin Crysvita Injection Product and Services
Table 6. Kyowa Kirin Crysvita Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Ultragenyx Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 8. Ultragenyx Pharmaceutical Major Business
Table 9. Ultragenyx Pharmaceutical Crysvita Injection Product and Services
Table 10. Ultragenyx Pharmaceutical Crysvita Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Global Crysvita Injection Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 12. Global Crysvita Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 13. Market Position of Manufacturers in Crysvita Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 14. Global Crysvita Injection Production Capacity by Company, (K Units): 2020 VS 2021
Table 15. Head Office and Crysvita Injection Production Site of Key Manufacturer
Table 16. Crysvita Injection New Entrant and Capacity Expansion Plans
Table 17. Crysvita Injection Mergers & Acquisitions in the Past Five Years
Table 18. Global Crysvita Injection Sales by Region (2017-2022) & (K Units)
Table 19. Global Crysvita Injection Sales by Region (2023-2028) & (K Units)
Table 20. Global Crysvita Injection Revenue by Region (2017-2022) & (USD Million)
Table 21. Global Crysvita Injection Revenue by Region (2023-2028) & (USD Million)
Table 22. Global Crysvita Injection Sales by Type (2017-2022) & (K Units)
Table 23. Global Crysvita Injection Sales by Type (2023-2028) & (K Units)
Table 24. Global Crysvita Injection Revenue by Type (2017-2022) & (USD Million)
Table 25. Global Crysvita Injection Revenue by Type (2023-2028) & (USD Million)
Table 26. Global Crysvita Injection Price by Type (2017-2022) & (US$/Unit)
Table 27. Global Crysvita Injection Price by Type (2023-2028) & (US$/Unit)
Table 28. Global Crysvita Injection Sales by Application (2017-2022) & (K Units)
Table 29. Global Crysvita Injection Sales by Application (2023-2028) & (K Units)
Table 30. Global Crysvita Injection Revenue by Application (2017-2022) & (USD Million)
Table 31. Global Crysvita Injection Revenue by Application (2023-2028) & (USD Million)
Table 32. Global Crysvita Injection Price by Application (2017-2022) & (US$/Unit)
Table 33. Global Crysvita Injection Price by Application (2023-2028) & (US$/Unit)
Table 34. North America Crysvita Injection Sales by Country (2017-2022) & (K Units)
Table 35. North America Crysvita Injection Sales by Country (2023-2028) & (K Units)
Table 36. North America Crysvita Injection Revenue by Country (2017-2022) & (USD Million)
Table 37. North America Crysvita Injection Revenue by Country (2023-2028) & (USD Million)
Table 38. North America Crysvita Injection Sales by Type (2017-2022) & (K Units)
Table 39. North America Crysvita Injection Sales by Type (2023-2028) & (K Units)
Table 40. North America Crysvita Injection Sales by Application (2017-2022) & (K Units)
Table 41. North America Crysvita Injection Sales by Application (2023-2028) & (K Units)
Table 42. Europe Crysvita Injection Sales by Country (2017-2022) & (K Units)
Table 43. Europe Crysvita Injection Sales by Country (2023-2028) & (K Units)
Table 44. Europe Crysvita Injection Revenue by Country (2017-2022) & (USD Million)
Table 45. Europe Crysvita Injection Revenue by Country (2023-2028) & (USD Million)
Table 46. Europe Crysvita Injection Sales by Type (2017-2022) & (K Units)
Table 47. Europe Crysvita Injection Sales by Type (2023-2028) & (K Units)
Table 48. Europe Crysvita Injection Sales by Application (2017-2022) & (K Units)
Table 49. Europe Crysvita Injection Sales by Application (2023-2028) & (K Units)
Table 50. Asia-Pacific Crysvita Injection Sales by Region (2017-2022) & (K Units)
Table 51. Asia-Pacific Crysvita Injection Sales by Region (2023-2028) & (K Units)
Table 52. Asia-Pacific Crysvita Injection Revenue by Region (2017-2022) & (USD Million)
Table 53. Asia-Pacific Crysvita Injection Revenue by Region (2023-2028) & (USD Million)
Table 54. Asia-Pacific Crysvita Injection Sales by Type (2017-2022) & (K Units)
Table 55. Asia-Pacific Crysvita Injection Sales by Type (2023-2028) & (K Units)
Table 56. Asia-Pacific Crysvita Injection Sales by Application (2017-2022) & (K Units)
Table 57. Asia-Pacific Crysvita Injection Sales by Application (2023-2028) & (K Units)
Table 58. South America Crysvita Injection Sales by Country (2017-2022) & (K Units)
Table 59. South America Crysvita Injection Sales by Country (2023-2028) & (K Units)
Table 60. South America Crysvita Injection Revenue by Country (2017-2022) & (USD Million)
Table 61. South America Crysvita Injection Revenue by Country (2023-2028) & (USD Million)
Table 62. South America Crysvita Injection Sales by Type (2017-2022) & (K Units)
Table 63. South America Crysvita Injection Sales by Type (2023-2028) & (K Units)
Table 64. South America Crysvita Injection Sales by Application (2017-2022) & (K Units)
Table 65. South America Crysvita Injection Sales by Application (2023-2028) & (K Units)
Table 66. Middle East & Africa Crysvita Injection Sales by Region (2017-2022) & (K Units)
Table 67. Middle East & Africa Crysvita Injection Sales by Region (2023-2028) & (K Units)
Table 68. Middle East & Africa Crysvita Injection Revenue by Region (2017-2022) & (USD Million)
Table 69. Middle East & Africa Crysvita Injection Revenue by Region (2023-2028) & (USD Million)
Table 70. Middle East & Africa Crysvita Injection Sales by Type (2017-2022) & (K Units)
Table 71. Middle East & Africa Crysvita Injection Sales by Type (2023-2028) & (K Units)
Table 72. Middle East & Africa Crysvita Injection Sales by Application (2017-2022) & (K Units)
Table 73. Middle East & Africa Crysvita Injection Sales by Application (2023-2028) & (K Units)
Table 74. Crysvita Injection Raw Material
Table 75. Key Manufacturers of Crysvita Injection Raw Materials
Table 76. Direct Channel Pros & Cons
Table 77. Indirect Channel Pros & Cons
Table 78. Crysvita Injection Typical Distributors
Table 79. Crysvita Injection Typical Customers
List of Figures
Figure 1. Crysvita Injection Picture
Figure 2. Global Crysvita Injection Revenue Market Share by Type in 2021
Figure 3. 10 mg/mL
Figure 4. 20 mg/mL
Figure 5. 30 mg/mL
Figure 6. Global Crysvita Injection Revenue Market Share by Application in 2021
Figure 7. Children
Figure 8. Adults
Figure 9. Global Crysvita Injection Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Crysvita Injection Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Crysvita Injection Sales (2017-2028) & (K Units)
Figure 12. Global Crysvita Injection Price (2017-2028) & (US$/Unit)
Figure 13. Global Crysvita Injection Production Capacity (2017-2028) & (K Units)
Figure 14. Global Crysvita Injection Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Crysvita Injection Market Drivers
Figure 16. Crysvita Injection Market Restraints
Figure 17. Crysvita Injection Market Trends
Figure 18. Global Crysvita Injection Sales Market Share by Manufacturer in 2021
Figure 19. Global Crysvita Injection Revenue Market Share by Manufacturer in 2021
Figure 20. Crysvita Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Crysvita Injection Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Crysvita Injection Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Crysvita Injection Sales Market Share by Region (2017-2028)
Figure 24. Global Crysvita Injection Revenue Market Share by Region (2017-2028)
Figure 25. North America Crysvita Injection Revenue (2017-2028) & (USD Million)
Figure 26. Europe Crysvita Injection Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Crysvita Injection Revenue (2017-2028) & (USD Million)
Figure 28. South America Crysvita Injection Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Crysvita Injection Revenue (2017-2028) & (USD Million)
Figure 30. Global Crysvita Injection Sales Market Share by Type (2017-2028)
Figure 31. Global Crysvita Injection Revenue Market Share by Type (2017-2028)
Figure 32. Global Crysvita Injection Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Crysvita Injection Sales Market Share by Application (2017-2028)
Figure 34. Global Crysvita Injection Revenue Market Share by Application (2017-2028)
Figure 35. Global Crysvita Injection Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Crysvita Injection Sales Market Share by Type (2017-2028)
Figure 37. North America Crysvita Injection Sales Market Share by Application (2017-2028)
Figure 38. North America Crysvita Injection Sales Market Share by Country (2017-2028)
Figure 39. North America Crysvita Injection Revenue Market Share by Country (2017-2028)
Figure 40. United States Crysvita Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Crysvita Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Crysvita Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Crysvita Injection Sales Market Share by Type (2017-2028)
Figure 44. Europe Crysvita Injection Sales Market Share by Application (2017-2028)
Figure 45. Europe Crysvita Injection Sales Market Share by Country (2017-2028)
Figure 46. Europe Crysvita Injection Revenue Market Share by Country (2017-2028)
Figure 47. Germany Crysvita Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Crysvita Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Crysvita Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Crysvita Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Crysvita Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Crysvita Injection Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Crysvita Injection Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Crysvita Injection Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Crysvita Injection Revenue Market Share by Region (2017-2028)
Figure 56. China Crysvita Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Crysvita Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Crysvita Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Crysvita Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Crysvita Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Crysvita Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Crysvita Injection Sales Market Share by Type (2017-2028)
Figure 63. South America Crysvita Injection Sales Market Share by Application (2017-2028)
Figure 64. South America Crysvita Injection Sales Market Share by Country (2017-2028)
Figure 65. South America Crysvita Injection Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Crysvita Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Crysvita Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Crysvita Injection Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Crysvita Injection Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Crysvita Injection Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Crysvita Injection Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Crysvita Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Crysvita Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Crysvita Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Crysvita Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Crysvita Injection in 2021
Figure 77. Manufacturing Process Analysis of Crysvita Injection
Figure 78. Crysvita Injection Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のクリスビタ市場2022年：市場規模予測（～2028年）
  • クリースビータのグローバル市場展望 2023年-2029年：10mg、20mg、30mg
  • 世界のリラグルチド注射市場2022年：市場規模予測（～2028年）
  • 世界のエダラボン注射市場2022年：市場規模予測（～2028年）
  • 世界のバシリキシマブ注射市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19251 )"世界のクリスビタ注射市場2022年：市場規模予測（～2028年）" (英文：Global Crysvita Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。